Lower expression of the LRRC8A gene is associated with reduced sensitivity of breast cancer patients to chemotherapy drugs such as BX-912, AR-42, AT-7519, BHG712, CAL-101, and CAY10603. Here, LRRC8A is linked to breast carcinoma.